¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024³â Çѱ¹½Å°æ¾È°úÇÐȸ Workshop : 2024-04-27

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024³â Çѱ¹½Å°æ¾È°úÇÐȸ Workshop : 2024-04-27
±³À°ÀÏÀÚ : 2024-04-27
±³À°Àå¼Ò : »ï¼º¼­¿ïº´¿ø ¾Ïº´¿ø ÁöÇÏ1Ãþ ´ë°­´ç

±³À°ÁÖÁ¦ : 2024³â Çѱ¹½Å°æ¾È°úÇÐȸ Workshop

ÁÖÃÖ±â°ü : ´ëÇѾȰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Çѱ¹½Å°æ¾È°úÇÐȸ

´ã´çÀÚ : Ãֹμ®
¿¬¶ôó : 02-2088-2128

À̸ÞÀÏ : info@pcocms.com

±³À°Á¾·ù : ¾È°ú

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 4Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 5ºÐ

¼¼ºÎ¼ö°­·á : 10,000¿ø  

ºñ°í Çѱ¹½Å°æ¾È°úÇÐȸ ȸ¿ø¸¸ µî·Ï °¡´É


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±âŸ 04¿ù 27ÀÏ ´ë°­´ç 08:50~09:00 Àλ縻 ±èÇý¿µ(Çѱ¹½Å°æ¾È°úÇÐȸ ȸÀå)

±³À°½Ã°£ 04¿ù 27ÀÏ ´ë°­´ç 09:00~09:20 NMOSD: Management Updates & Challenging Cases Á¤ÀçÈ£(¼­¿ï´ëº´¿ø)

±³À°½Ã°£ 04¿ù 27ÀÏ ´ë°­´ç 09:20~09:40 Higher Cortical Visual Disorders ÀÌÀͼº(ºÎõ¼øõÇ⺴¿ø ½Å°æ°ú)

±³À°½Ã°£ 04¿ù 27ÀÏ ´ë°­´ç 09:40~10:00 Migraine & The Eye Á¤¼ºÇØ(Ãæ³²´ëº´¿ø ½Å°æ°ú)

Åä·Ð 04¿ù 27ÀÏ ´ë°­´ç 10:00~10:10 Discussion(Q&A) -(-)

ÈÞ½Ä 04¿ù 27ÀÏ ´ë°­´ç 10:10~10:20 Coffee Break -(-)

±³À°½Ã°£ 04¿ù 27ÀÏ ´ë°­´ç 10:20~10:40 Hot topic: MOG related disease, Idiopathic intracranial hypertension ÇѼҿµ(°­ºÏ»ï¼ºº´¿ø)

±³À°½Ã°£ 04¿ù 27ÀÏ ´ë°­´ç 10:40~11:00 Scientific platform: Traumatic optic neuropathy, Central retinal artery occlusion ±èÀç·É(»ï¼º¼­¿ïº´¿ø)

±³À°½Ã°£ 04¿ù 27ÀÏ ´ë°­´ç 11:00~11:20 Practical Use of OCT in Papilledema & Pseudopapilledema ¼­¿µ¿ì(°í·Á´ëº´¿ø)

±³À°½Ã°£ 04¿ù 27ÀÏ ´ë°­´ç 11:20~11:40 How Major Neuro-Ophthalmic Trials are Applied Àüº¸¿µ(°æºÏ´ëº´¿ø)

±³À°½Ã°£ 04¿ù 27ÀÏ ´ë°­´ç 11:40~12:00 When We Make Errors and Do Harm ½ÅÇöÁø(°Ç±¹´ëº´¿ø)

Åä·Ð 04¿ù 27ÀÏ ´ë°­´ç 12:00~12:10 Discussion(Q&A) -(-)

±³À°½Ã°£ 04¿ù 27ÀÏ ´ë°­´ç 12:20~12:35 Idebenone, New Drug to Treat for LHON Patients Çãȯ(Àü³²´ëº´¿ø)

±³À°½Ã°£ 04¿ù 27ÀÏ ´ë°­´ç 12:35~12:50 New Clinical Data of Idebenone: LEROS Study ÃÖÈñ¿µ(ºÎ»ê´ëº´¿ø)

Åä·Ð 04¿ù 27ÀÏ ´ë°­´ç 12:50~13:00 Discussion(Q&A) -(-)

ÈÞ½Ä 04¿ù 27ÀÏ ´ë°­´ç 13:00~13:10 Coffee Break -(-)

±³À°½Ã°£ 04¿ù 27ÀÏ ´ë°­´ç 13:10~13:25 Update in Neuro-Ophthalmology 1 ±èµ¿Çö(¼­¿ï´ëº´¿ø)

±³À°½Ã°£ 04¿ù 27ÀÏ ´ë°­´ç 13:25~13:40 Update in Neuro-Ophthalmology 2 ÀÌÇàÁø(ÀüºÏ´ëº´¿ø)

±³À°½Ã°£ 04¿ù 27ÀÏ ´ë°­´ç 13:40~13:55 Update in Optic Neuritis À̵¿ÈÆ(´ë±¸°¡Å縯´ëº´¿ø)

±³À°½Ã°£ 04¿ù 27ÀÏ ´ë°­´ç 13:55~14:10 Update in Ischemic Optic Neuropathy ¼ºÀ翬(¼¼Á¾Ãæ³²´ëº´¿ø)

±³À°½Ã°£ 04¿ù 27ÀÏ ´ë°­´ç 14:10~14:25 Hereditary Optic Neuropathy È«ÀºÈñ(ÇѾç´ë±¸¸®º´¿ø)

Åä·Ð 04¿ù 27ÀÏ ´ë°­´ç 14:25~14:35 Discussion(Q&A) -(-)

±³À°½Ã°£ 04¿ù 27ÀÏ ´ë°­´ç 14:35~14:55 Case 1. One Disease with Two Faces ÇÑÁø¿ì(°­³²¼¼ºê¶õ½ºº´¿ø)

±³À°½Ã°£ 04¿ù 27ÀÏ ´ë°­´ç 14:55~15:15 Case 2. The Unseen Thief ¹Ú°æ¾Æ(»ï¼º¼­¿ïº´¿ø)

±³À°½Ã°£ 04¿ù 27ÀÏ ´ë°­´ç 15:15~15:35 Case 3. It¡¯s Okay to Burn the Bridge ±èÇý¿µ(±¹¹Î°Ç°­º¸Çè Àϻ꺴¿ø)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024³â Çѱ¹½Å°æ¾È°úÇÐȸ Workshop : 2024-04-27""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) 2024³â Á¦1Â÷ °í·Á´ëÇб³ ¾È»êº´¿ø Á¤Çü¿Ü°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-04-27
´ÙÀ½±Û ¼¼°èÀ¯¹æ¾ÏÇмú´ëȸ 2024 ¹× Çѱ¹À¯¹æ¾ÏÇмú´ëȸ (GBCC 2024) (2ÀÏÂ÷) : 2024-04-26
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
270 ¼­¿ï ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ Á¦53Â÷ ¾Ë·¹¸£±â ±³À°°­Á : 2018-09-16 0 576 2018-07-28
269 ¼­¿ï 2018³â Á¦3ȸ »ï¼º¼­¿ïº´¿ø ¿Ü°ú ½ÉÆ÷Áö¿ò : 2018-09-16 0 938 2018-07-28
268 ´ë±¸ 2018³âµµ ´ëÇÑÁ¤Çü¿Ü°úÀÇ»çȸ Çмú´ëȸ : 2018-09-16 0 826 2018-07-28
267 ¼­¿ï ½ÉÀå´ë»çÁõÈıº¿¬±¸È¸ 2018 Ãß°è½ÉÆ÷Áö¾ö : 2018-09-15 0 677 2018-07-28
266 ¼­¿ï °æÈñ´ëÇб³º´¿ø µ¿¹®Áý´ãȸ_°íȲÀ̺ñÀÎÈÄ°ú ¿¬±¸È¸ ¼¼¹Ì³ª : 2018-09-15 0 1,401 2018-07-28
265 ¼­¿ï 2018 Çѱ¹Á¤½ÅºÐ¼®ÇÐȸ Á¤½ÅÄ¡·á Àü¹®°úÁ¤ : °æ°è¼± ÀΰÝÀå¾Ö : 2018-09-15 0 1,177 2018-07-28
264 ¼­¿ï ¼­¿ï¼º¸ðº´¿ø ½ÅÀåÀÌ½Ä 3,000·Ê ±â³ä ´ëÇÑÀ̽ÄÇÐȸ °øµ¿ ½ÉÆ÷Áö¾ö : 2018-09-15 0 619 2018-07-28
263 °­¿ø ´ëÇÑ°ñÀýÇÐȸ Á¦2ȸ ÇÏÁö°ñÀý ½ÉÆ÷Áö¾ö : 2018-09-15 0 577 2018-07-28
262 Àü³² ¸ñÆ÷½ÃÀÇ»çȸ Çмú´ëȸ(°æµ¿¸Æ¼Õ»ó,°áÇÙ) : 2018-09-15 0 2,687 2018-07-28
261 ¼­¿ï °í·Á´ëÇб³ ½Å°æ°úÇб³½Ç ½ÉÆ÷Áö¿ò : 2018-09-15 0 1,940 2018-07-28
260 °æ±â ºÐ´ç¼­¿ï´ëÇб³º´¿ø ÄÚºí·¹ÀÌÅ͸¦ ÀÌ¿ëÇÑ ´Ù¾çÇÑ ºñ°ú ¼ö¼úµé : 2018-09-15 0 763 2018-07-28
259 °æ±â Á¦6ȸ ÇѸ²´ëÇб³¼º½Éº´¿ø Á¤Çü¿Ü°ú °³¿øÀÇ ½ÉÆ÷Áö¿ò : 2018-09-15 0 876 2018-07-28
258 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø ¾È°ú ±Ý¿ä¼¼¹Ì³ª : 2018-09-14 0 621 2018-07-28
257 ¼­¿ï »ï¼º¼­¿ïº´¿ø 2018 »ï¼º ¾È°ú ±Ý¿äÁý´ãȸ : 2018-09-14 0 657 2018-07-28
256 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø 2018 ÀÇ·áÇöÀå¿¡¼­ ¸¸³ª´Â ¾à¹°¾Ë·¹¸£±â : 2018-09-14 0 822 2018-07-28
1371 | 1372 | 1373 | 1374 | 1375 | 1376 | 1377 | 1378 | 1379 | 1380
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷